Rituximab for severe myasthenia gravis - Experience from five patients

Acta Neurologica Scandinavica

Volumn 122, Issue 4, 2010, Pages 225-228

  Lindberg, C ^a   Bokarewa, M ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

myasthenia gravis; rituximab; thymoma

Indexed keywords

AZATHIOPRINE; CLEMASTINE; CYCLOSPORIN A; HYDROCORTISONE SODIUM SUCCINATE; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PARACETAMOL; PREDNISOLONE; RITUXIMAB;

ADULT; ARTICLE; CLINICAL ARTICLE; DETERIORATION; DISEASE DURATION; DRUG EFFICACY; DYSPNEA; FEMALE; FORCED VITAL CAPACITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MYASTHENIA GRAVIS; PLASMAPHERESIS; PREMEDICATION; RECURRENCE RISK; THYMOMA; WEAKNESS;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MALE; MYASTHENIA GRAVIS; TREATMENT OUTCOME;

EID: 77956418989     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2010.01345.x     Document Type: Article

References (13)

1. Gürcan HM, Keskin DB, Stern JN, Nitzberg MA, Shekhani H, Razzaque Ahmed R A review of the current use of rituximab in autoimmune diseases. Int Immunopharmacol 2009 9 : 10 25.
2. Zaja F, Russo D, Fuga G, Perella G, Baccarani M. Rituximab for myasthenia gravis developing after bone marrow transplantation. Neurology 2000 55 : 1062 1063.
3. Wylam ME, Anderson PM, Kuntz NL, Rodriguez V. Successful treatment of refractory myasthenia gravis using Rituximab: a pediatric case report. J Pediatr 2003 143 : 674 677.
4. Gajra A, Vajpayee N, Grethlein SJ. Response of myasthenia gravis to Rituximab in a patient with non-Hodkin lymphoma. Am J Hematol 2004 77 : 196 197.
5. Thakre M, Inshasi J, Marashi M. Rituximab in refractory MuSK antibody myasthenia gravis. J Neurol 2007 254 : 968 969.
6. Illa I, Diaz-Manera J, Rojas-Garcia R et al. Sustained response to Rituximab in anti-AChR and anti-MuSK positive myasthenia gravis patients. J Neuroimmunol 2008 15 : 90 4.
7. Nelson RP Jr., Pascuzzi RM, Kessler K et al. Rituximab for the treatment of thymoma-associated and de novo myasthenia gravis: 3 cases and a review. J Clin Neuromuscul Dis 2009 10 : 170 177.
8. Lebrun C, Bourg V, Tieulie N, Thomas P. Successful treatment of refractory generalized myasthenia gravis with rituximab. Eur J Neurol 2009 16 : 246 250.
9. Stieglbauer K, Topakian R, Schäffer V, Aichner FT. Rituximab for myasthenia gravis. Three case reports and review of the literature. J Neurol Sci 2009 280 : 120 122.
10. Hain B, Jordan K, Deschauer M, Zierz S. Successful treatment of MuSK antibody-positive myasthenia gravis with rituximab. Muscle Nerve 2006 33 : 575 580.
11. Lin PT, Martin BA, Weinacker AB, So YT. High-dose cyclophosphamide in refractory myasthenia gravis with MuSK antibodies. Muscle Nerve 2006 33 : 433 435.
12. Strober J, Cowan MJ, Horn BN. Allogeneic hematopoietic cell transplantation for refractory myasthenia gravis. Arch Neurol 2009 66 : 659 561.
13. Jaretzki A, Barohn RJ, Ernstoff RM et al. Myasthenia gravis. Recommendations for clinical research standards. Neurology 2000 55 : 16 23.